3 Small-Cap Stocks That Fall Short
Mr. Riga brings over 25 years of commercial and operational experience with proven success leading transformative corporate development strategies and transactions
Positive Phase 3 HERIZON-GEA-01 results support Ziihera as the HER2-targeted agent-of-choice in HER2+ first-line metastatic GEA and Ziihera plus chemotherapy to replace trastuzumab as the new...
Reflecting On Pharmaceuticals Stocks’ Q3 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ)
3 Mid-Cap Stocks with Warning Signs
3 Reasons JAZZ is Risky and 1 Stock to Buy Instead
DUBLIN , Dec. 17, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the following investor events:
3 Value Stocks We’re Skeptical Of
New interim results from the EpiCom trial, a prospective evaluation of behavioral outcomes in patients with tuberous sclerosis complex, suggest improvements in non-seizure outcomes
3 Healthcare Stocks We’re Skeptical Of